Generalized osteoporosis of mixed origin with severe compression fractures and pain syndrome
He main issue in osteoporosis management is the duration of treatment with different drugs particularly in cases of severe osteoporosis with high fracture risks and indications of switching from one to other agents. Denosumab is a new class of osteoporosis treatment called a human monoclonal antibod...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Endocrinology Research Centre
2013-12-01
|
| Series: | Ожирение и метаболизм |
| Subjects: | |
| Online Access: | https://www.omet-endojournals.ru/jour/article/view/6388 |